246 related articles for article (PubMed ID: 25860851)
21. Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy.
Curatolo P
Pediatr Neurol; 2015 Mar; 52(3):281-9. PubMed ID: 25591831
[TBL] [Abstract][Full Text] [Related]
22. TuberOus SClerosis Registry to Increase Disease Awareness: A Review on Alignment of Its Planning, Execution, and Publications With European Medicines Agency Guidelines.
Marques R; Thole H; Ruiz de Morales JG
Front Neurol; 2020; 11():365. PubMed ID: 32499750
[TBL] [Abstract][Full Text] [Related]
23. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference.
Krueger DA; Northrup H;
Pediatr Neurol; 2013 Oct; 49(4):255-65. PubMed ID: 24053983
[TBL] [Abstract][Full Text] [Related]
24. [Guidelines for the management of tuberous sclerosis complex renal disease].
Rouvière O; Nivet H; Grenier N; Zini L; Lechevallier E
Prog Urol; 2012 Jun; 22(7):367-79. PubMed ID: 22657256
[TBL] [Abstract][Full Text] [Related]
25. Possible prevention of tuberous sclerosis complex lesions.
Kotulska K; Borkowska J; Jozwiak S
Pediatrics; 2013 Jul; 132(1):e239-42. PubMed ID: 23733802
[TBL] [Abstract][Full Text] [Related]
26. Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex.
MacKeigan JP; Krueger DA
Neuro Oncol; 2015 Dec; 17(12):1550-9. PubMed ID: 26289591
[TBL] [Abstract][Full Text] [Related]
27. [Diagnosis, monitoring and treatment of tuberous sclerosis complex].
Reinhard M; Sunde L; Madsen MG; Andersen BN; Bendstrup E; Sommerlund M; Gjørup H; Larsen DA; Møller HU; Nielsen DG; Mortensen UM; Handrup MM; Aagaard NKM; Cortnum S; Khatir DS; Bayat M; Andersen G; Stausbøl-Grøn B; Christensen J
Ugeskr Laeger; 2019 Nov; 181(45):. PubMed ID: 31791451
[TBL] [Abstract][Full Text] [Related]
28. International consensus recommendations for the identification and treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND).
de Vries PJ; Heunis TM; Vanclooster S; Chambers N; Bissell S; Byars AW; Flinn J; Gipson TT; van Eeghen AM; Waltereit R; Capal JK; Cukier S; Davis PE; Smith C; Kingswood JC; Schoeters E; Srivastava S; Takei M; Gardner-Lubbe S; Kumm AJ; Krueger DA; Sahin M; De Waele L; Jansen AC
J Neurodev Disord; 2023 Sep; 15(1):32. PubMed ID: 37710171
[TBL] [Abstract][Full Text] [Related]
29. Primary care management of tuberous sclerosis complex in children.
Manohara D
J Am Acad Nurse Pract; 2012 Jul; 24(7):391-9. PubMed ID: 22735062
[TBL] [Abstract][Full Text] [Related]
30. The UK guidelines for management and surveillance of Tuberous Sclerosis Complex.
Amin S; Kingswood JC; Bolton PF; Elmslie F; Gale DP; Harland C; Johnson SR; Parker A; Sampson JR; Smeaton M; Wright I; O'Callaghan FJ
QJM; 2019 Mar; 112(3):171-182. PubMed ID: 30247655
[TBL] [Abstract][Full Text] [Related]
31. Clinical practice recommendations for kidney involvement in tuberous sclerosis complex: a consensus statement by the ERKNet Working Group for Autosomal Dominant Structural Kidney Disorders and the ERA Genes & Kidney Working Group.
Mekahli D; Müller RU; Marlais M; Wlodkowski T; Haeberle S; de Argumedo ML; Bergmann C; Breysem L; Fladrowski C; Henske EP; Janssens P; Jouret F; Kingswood JC; Lattouf JB; Lilien M; Maleux G; Rozenberg M; Siemer S; Devuyst O; Schaefer F; Kwiatkowski DJ; Rouvière O; Bissler J
Nat Rev Nephrol; 2024 Jun; 20(6):402-420. PubMed ID: 38443710
[TBL] [Abstract][Full Text] [Related]
32. Tuberous sclerosis complex: new insights into clinical and therapeutic approach.
Volpi A; Sala G; Lesma E; Labriola F; Righetti M; Alfano RM; Cozzolino M
J Nephrol; 2019 Jun; 32(3):355-363. PubMed ID: 30406604
[TBL] [Abstract][Full Text] [Related]
33. Are diagnostic criteria for tuberous sclerosis still relevant?
Roach ES
Pediatr Neurol; 2013 Oct; 49(4):223-4. PubMed ID: 24053981
[No Abstract] [Full Text] [Related]
34. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference.
Northrup H; Krueger DA;
Pediatr Neurol; 2013 Oct; 49(4):243-54. PubMed ID: 24053982
[TBL] [Abstract][Full Text] [Related]
35. Review of the Tuberous Sclerosis Renal Guidelines from the 2012 Consensus Conference: Current Data and Future Study.
Kingswood JC; Bissler JJ; Budde K; Hulbert J; Guay-Woodford L; Sampson JR; Sauter M; Cox J; Patel U; Elmslie F; Anderson C; Zonnenberg BA
Nephron; 2016; 134(2):51-58. PubMed ID: 27504842
[TBL] [Abstract][Full Text] [Related]
36. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria.
Roach ES; Gomez MR; Northrup H
J Child Neurol; 1998 Dec; 13(12):624-8. PubMed ID: 9881533
[TBL] [Abstract][Full Text] [Related]
37. Autism Phenotypes in Tuberous Sclerosis Complex: Diagnostic and Treatment Considerations.
Gipson TT; Poretti A; Thomas EA; Jenkins KT; Desai S; Johnston MV
J Child Neurol; 2015 Dec; 30(14):1871-6. PubMed ID: 26303410
[TBL] [Abstract][Full Text] [Related]
38. Involvement of mental health professionals in the treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND): results of a multinational European electronic survey.
Waltereit R; Beaure d'Augères G; Jancic J; Kingswood JC; Koleva M; Marques R; Villanueva V; Auvin S
Orphanet J Rare Dis; 2021 May; 16(1):216. PubMed ID: 33980296
[TBL] [Abstract][Full Text] [Related]
39. Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosis.
Franz DN
Expert Rev Anticancer Ther; 2011 Aug; 11(8):1181-92. PubMed ID: 21916571
[TBL] [Abstract][Full Text] [Related]
40. Tuberous sclerosis complex: Concerns and needs of patients and parents from the transitional period to adulthood.
Both P; Ten Holt L; Mous S; Patist J; Rietman A; Dieleman G; Ten Hoopen L; Vergeer M; de Wit MC; Bindels-de Heus K; Moll H; van Eeghen A
Epilepsy Behav; 2018 Jun; 83():13-21. PubMed ID: 29631156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
